[go: up one dir, main page]

IL140603A0 - Agents with an antidepressive effect - Google Patents

Agents with an antidepressive effect

Info

Publication number
IL140603A0
IL140603A0 IL14060399A IL14060399A IL140603A0 IL 140603 A0 IL140603 A0 IL 140603A0 IL 14060399 A IL14060399 A IL 14060399A IL 14060399 A IL14060399 A IL 14060399A IL 140603 A0 IL140603 A0 IL 140603A0
Authority
IL
Israel
Prior art keywords
agents
antidepressive effect
antidepressive
effect
Prior art date
Application number
IL14060399A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL140603A0 publication Critical patent/IL140603A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14060399A 1998-07-07 1999-07-02 Agents with an antidepressive effect IL140603A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (1)

Publication Number Publication Date
IL140603A0 true IL140603A0 (en) 2002-02-10

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14060399A IL140603A0 (en) 1998-07-07 1999-07-02 Agents with an antidepressive effect

Country Status (32)

Country Link
US (1) US6255329B1 (es)
EP (1) EP1093369B1 (es)
JP (1) JP2002520273A (es)
KR (1) KR100557692B1 (es)
CN (1) CN1230168C (es)
AR (1) AR019896A1 (es)
AT (1) ATE228365T1 (es)
AU (1) AU762128B2 (es)
BG (1) BG64972B1 (es)
BR (1) BR9911768A (es)
CA (1) CA2336833C (es)
CZ (1) CZ294087B6 (es)
DE (2) DE19830201A1 (es)
DK (1) DK1093369T3 (es)
EA (1) EA003142B1 (es)
EE (1) EE04296B1 (es)
ES (1) ES2183583T3 (es)
HU (1) HUP0103922A3 (es)
ID (1) ID27776A (es)
IL (1) IL140603A0 (es)
MY (1) MY117969A (es)
NO (1) NO20010064L (es)
NZ (1) NZ509729A (es)
PL (1) PL195043B1 (es)
PT (1) PT1093369E (es)
RS (1) RS49795B (es)
SK (1) SK284923B6 (es)
TR (1) TR200100146T2 (es)
TW (1) TW592698B (es)
WO (1) WO2000002542A2 (es)
YU (1) YU401A (es)
ZA (1) ZA200100090B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
HUP0500001A3 (en) * 2001-12-11 2005-11-28 Univ Virginia Use of pramipexole to treat amyotrophic lateral sclerosis
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
EP1708706A1 (en) * 2004-01-22 2006-10-11 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
EP1917014B1 (en) * 2005-08-15 2009-10-07 University Of Virginia Patent Foundation Neurorestoration with r(+) pramipexole
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
DK2026803T3 (da) 2006-05-16 2012-04-16 Knopp Neurosciences Inc Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
AU2008224844B2 (en) 2007-03-14 2012-08-09 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
CA2734491A1 (en) * 2008-08-19 2010-02-25 Knopp Neurosciences, Inc. Compositions and methods of using (r)-pramipexole
US20100069390A1 (en) 2008-09-05 2010-03-18 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (ADHD)
JP2012525426A (ja) * 2009-04-30 2012-10-22 スパーナス ファーマシューティカルズ インコーポレイテッド うつ病を治療する方法
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
EP4233915A3 (en) 2012-02-08 2023-09-20 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
ES3043076T3 (en) 2013-07-12 2025-11-24 Areteia Therapeutics Inc Treating elevated levels of eosinophils and/or basophils
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
AU2014306683B2 (en) 2013-08-13 2017-10-12 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
EP3033081B1 (en) 2013-08-13 2021-05-12 Knopp Biosciences LLC Compositions and methods for treating chronic urticaria
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
CN111032158A (zh) 2017-06-30 2020-04-17 才思治疗公司 用于治疗抑郁的nk-1拮抗剂组合物和方法
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
CA2249603A1 (en) * 1996-03-29 1997-10-09 Pfizer Inc. Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
WO1998024446A1 (en) * 1996-12-02 1998-06-11 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating movement disorders
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法

Also Published As

Publication number Publication date
CA2336833A1 (en) 2000-01-20
ES2183583T3 (es) 2003-03-16
SK284923B6 (sk) 2006-02-02
WO2000002542A3 (de) 2000-06-22
DK1093369T3 (da) 2002-12-16
HUP0103922A2 (hu) 2002-03-28
DE59903556D1 (de) 2003-01-09
EP1093369B1 (de) 2002-11-27
AU762128B2 (en) 2003-06-19
CN1308533A (zh) 2001-08-15
YU401A (sh) 2003-10-31
WO2000002542A2 (de) 2000-01-20
EP1093369A2 (de) 2001-04-25
KR100557692B1 (ko) 2006-03-07
CZ200177A3 (en) 2001-06-13
KR20010079491A (ko) 2001-08-22
JP2002520273A (ja) 2002-07-09
TW592698B (en) 2004-06-21
NO20010064D0 (no) 2001-01-05
BG64972B1 (bg) 2006-11-30
CA2336833C (en) 2008-09-23
PT1093369E (pt) 2003-03-31
AR019896A1 (es) 2002-03-20
PL345842A1 (en) 2002-01-14
BR9911768A (pt) 2001-04-03
US6255329B1 (en) 2001-07-03
EE04296B1 (et) 2004-06-15
ZA200100090B (en) 2002-04-04
BG105112A (bg) 2001-10-31
AU5030399A (en) 2000-02-01
EA003142B1 (ru) 2003-02-27
SK112001A3 (en) 2001-10-08
CZ294087B6 (cs) 2004-10-13
DE19830201A1 (de) 2000-01-13
HUP0103922A3 (en) 2002-08-28
EA200100084A1 (ru) 2001-08-27
NZ509729A (en) 2003-06-30
ATE228365T1 (de) 2002-12-15
ID27776A (id) 2001-04-26
CN1230168C (zh) 2005-12-07
PL195043B1 (pl) 2007-08-31
TR200100146T2 (tr) 2001-07-23
NO20010064L (no) 2001-03-02
MY117969A (en) 2004-08-30
RS49795B (sr) 2008-06-05
EE200100014A (et) 2002-06-17
HK1037976A1 (en) 2002-03-01

Similar Documents

Publication Publication Date Title
PL345842A1 (en) Agents with an antidepressive effect
AU138171S (en) Goggles
PL343923A1 (en) New use
EP1103829A4 (en) POLARIZER
GB9818914D0 (en) Use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
GB2337549B (en) Retaining components
GB9808496D0 (en) Resistance-monitoring arrangement
HUP0105165A3 (en) Lichting arrangement
GB2335259B (en) An explosion-suppressing structure
GB9807503D0 (en) Use
GB9828004D0 (en) Use
GB9817064D0 (en) New use
GB2339003B (en) Movement-damping arrangements
GB9826348D0 (en) Advance arrangement
GB2337526B (en) Easy rockeries
PL324932A1 (en) Mould-killing agent
GB9823217D0 (en) Quick quion
TW348390U (en) Auto-bating device with multi-hooks
CA83191S (en) Dickie
GB9808779D0 (en) Concept one
GB9805590D0 (en) Use
GB9828003D0 (en) Use
GB9805593D0 (en) Earpieces
AU136060S (en) An elongate section

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees